Secondary Leukemia after breast cancer treatment

Selina M. Luger, MD
Ultima Vez Modificado: 17 de febrero del 2002

Translation for this article does not exist


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

Mutant U2AF1 ID'd in Acute Myeloid Leukemia

Dec 20, 2011

Patients with myelodysplastic syndrome who have U2AF1 mutation may progress to secondary AML

Pediatric High-Risk Leukemia Survival Has Improved Over Time

Jul 25, 2011

Improved AML/ALL outcomes following allogeneic, non-allogeneic hematopoietic cell transplantation

Specific Mutations in AML Affect Response to Therapy

Mar 15, 2012

Also, bone marrow cells in myelodysplastic syndromes, secondary AML are clonal